Novel fluorescent nanosensor enables real-time detection of indole-3-propionic acid (IPA), paving the way for faster gut health screening, point-of-care diagnostics, and wearable monitoring devices
GLP-1 therapies are among the fastest-growing drug classes worldwide, projected to drive a $95 billion obesity market by 2030
Globally, colorectal cancer impacts 1.9 million people each year, standing as a leading cause of cancer mortality
BioFluidica LiquidScan harnesses the power of microfluidics
New Gurugram centre is India's first clinical Prevention Centre with 2 state of the art MRI machines and a capacity of 2000 scans a month
.jpeg)
One of our major priorities in next 3-5 years is the introduction of a kit-based version of CanAssist Breast, enabling hospitals conduct the test locally
The decision was driven by results from the Phase III CAPItello-281 trial,
MeRT becomes one of the few FDA-cleared neuromodulation therapies for PTSD, using EEG biomarkers and AI to personalize treatment for patients with treatment-resistant symptoms
Advanced molecular diagnostics solution enables rapid, high-accuracy biomarker detection for precision oncology
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
